High Performance Solutions for Dpi Delivery: New Formulation and Device Platforms

Join Hovione experts to gain insights on novel formulation development strategies for DPIs and learn how to improve your drug delivery efficiency even at high drug loads

Register Free: https://www.pharmtech.com/pte_w/dpi-delivery

Event Overview:

This webinar will address the most relevant solutions for dry powder inhaler (DPI) development covering both formulation and device development, as well as process optimization and analytical characterization, under an integrated development approach. DPIs are the dosage form of choice for delivering high payloads of inhaled drugs and achieving maximum delivery efficiency to patients. This presentation will focus on new formulation platforms, aiming to address the pharmacokinetics requirements of the target drug and indication, coupled with a new device platform, the Sunriser® DPI. This integrated approach is designed to maximize drug delivery efficiency while maintaining safety, being able to address a diversified array of diseases.

Key Learning Objectives

• Gain insights on novel formulation development strategies for DPIs, to be able to improve drug delivery efficiency even at high drug loads;
• Understand the potential of wet milling and dry milling capabilities for boosting the fine particle dose of DPI formulations;
• Discover analytical characterization techniques, for differentiated formulations, to further understand product properties that impact drug delivery and aerodynamic performance;
• Understand features associated with a novel high efficiency device platform, the Sunriser® capsule-based Dry Powder Inhaler;
• Network with industry peers and experts during the live Q&A session.

Who Should Attend

• Pharmaceutical researchers and scientists
• CMC experts on inhalation drug delivery
• Business development, portfolio management and technology licensing experts
• Inhalation product development professionals
• Respiratory therapeutics specialists

Speakers:

Susana Saldanha, M.Sc.
R&D Manager, Inhalation and Advanced Drug Delivery
Hovione

Susana Saldanha is the manager of formulation and device development team, in the Inhalation and Advanced Drug Delivery Group at Hovione R&D. Susana has over 10 years of experience in formulation development and has supported the development of oral, transdermal, and injectable dosage forms, spanning from early drug product development through product registration to launch.
Susana joined Hovione in 2018 where she focused not only on drug delivery to the lungs but also nasal and ophthalmic drug delivery. She has worked on drug product development projects from early to later stages, ranging from generics to innovative products. Susana holds a PharmD from Faculty of Pharmacy, University of Coimbra.

Sofia Silva, M.Sc.
R&D Manager, Analytical development
Hovione

Sofia Silva is a senior manager in the Analytical development group at Hovione R&D. Sofia has over 15 years’ experience in analytical chemistry development specializing in inhalation drug products, from early to late phase development and drug product launch.
Sofia joined Hovione in 2009 and holds master’s degree in Pharmaceutical Sciences and Pharmaceutical Engineering.

Register Free: https://www.pharmtech.com/pte_w/dpi-delivery